Holly K. Tabor, PhD and Aaron Goldenberg, PhD, MPH
Rare genetic disease research has something to teach precision medicine about addressing some patients’ limited access to treatment. Health disparities exacerbated by high costs and limited availability of drugs can, perhaps, be mitigated when patient activism accelerates drug development.
AMA J Ethics. 2018;20(9):E834-840. doi:
10.1001/amajethics.2018.834.
The allocation of scarce resources, such as HLA platelets, involves a conflict between the medical ethics principles of beneficence and social justice.
AMA J Ethics. 2016;18(8):764-770. doi:
10.1001/journalofethics.2016.18.8.ecas1-1608.
After years of funding disease-specific treatment, donation trends have shifted to support broader health systems infrastructure development. A remaining challenge is how to sustain antiretroviral therapy (ART) for patients in resource-poor regions.
AMA J Ethics. 2016;18(7):681-690. doi:
10.1001/journalofethics.2016.18.7.ecas3-1607.
Thoughtful design can welcome patients’ families’ roles in promoting healing. At the same time, clinicians’ need for functionality and privacy is critical. How ought these considerations be balanced in designing the spaces where patient care takes place?
AMA J Ethics. 2016;18(1):73-76. doi:
10.1001/journalofethics.2017.18.1.sect1-1601.
In treating children with autism, physicians should reframe the common dynamic in which the family wants medication that the doctor is withholding to focus instead on the family’s and physician’s share goal—the patient’s well-being.
AMA J Ethics. 2015;17(4):299-304. doi:
10.1001/journalofethics.2015.17.4.ecas1-1504.
Jason D. Hall, JD, Lee A. Goeddel, MD, MPH, and Thomas R. Vetter, MD, MPH
In the perioperative surgical home, the anesthesiologist coordinates care with other team members to provide seamless continuity from preoperative evaluation to postoperative care.
AMA J Ethics. 2015;17(3):243-247. doi:
10.1001/journalofethics.2015.17.3.stas2-1503.